CruzDNFerrer-NadalAPiccinniP. Utilization of small changes in serum creatinine with clinical risk factors to assess the risk of AKI in critically III adults. Clin J Am Soc Nephrol. 2014;9(4):663–672.
2.
KoynerJLDavisonDLBrasha-MitchellE. Furosemide stress test and biomarkers for the prediction of AKI severity. J Am Soc Nephrol. 2015;26(8):2023–2031.
3.
VanmassenhoveJKielsteinJJorresABiesenWV. Management of patients at risk of acute kidney injury. Lancet. 2017;389(10084):2139–2151.
4.
ParikhCRDevarajanPZappitelliM. Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol. 2011;22(9):1737–1747.
5.
MaiselASWetterstenNvan VeldhuisenDJ. Neutrophil gelatinase-associated lipocalin for acute kidney injury during acute heart failure hospitalizations: the AKINESIS study. J Am Coll Cardiol. 2016;68(13):1420–1431.
6.
BagshawSMBennettMHaaseM. Plasma and urine neutrophil gelatinase-associated lipocalin in septic versus non-septic acute kidney injury in critical illness. Intensive Care Med. 2010;36(3):452–461.
7.
VanmassenhoveJGlorieuxGLameireN. Influence of severity of illness on neutrophil gelatinase-associated lipocalin performance as a marker of acute kidney injury: a prospective cohort study of patients with sepsis. BMC Nephrol. 2015;16:18.
